Multiple and aggressive keratoacanthomas associated with Ferguson-Smith syndrome, successfully treated by cetuximab and cisplatin

Eur J Dermatol. 2021 Apr 1;31(2):271-272. doi: 10.1684/ejd.2021.4025.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma / complications
  • Carcinoma / drug therapy*
  • Cetuximab / administration & dosage
  • Cisplatin / administration & dosage
  • Facial Dermatoses / complications
  • Facial Dermatoses / therapy*
  • Facial Neoplasms / complications
  • Facial Neoplasms / drug therapy*
  • Female
  • Humans
  • Keratoacanthoma / complications
  • Keratoacanthoma / drug therapy
  • Keratoacanthoma / therapy*
  • Recurrence
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Squamous Cell Carcinoma of Head and Neck / drug therapy*

Substances

  • Cetuximab
  • Cisplatin

Supplementary concepts

  • Keratoacanthoma familial